RSM, the world 6th largest consulting and auditing network, carried out the financial, tax and payroll due diligence for ProductLife Groupe (PLG), a regulatory consulting firm for the life sciences industry, during the acquisition of Intexo Società Benefit, an Italian regulatory consultancy in the healthcare sector.

To support ProductLife Group, RSM partners Eric Fougedoire, Lucas D’Ambrosio and Kristian Bresciani led a multidisciplinary Franco-Italian team.

Following the acquisition of Zwiers Regulatory Consultancy and Cilatus, this is the third external growth operation entrusted to RSM's Corporate Finance division. With these transactions, RSM has demonstrated its ability to support life sciences sector players in their strategic acquisitions in Europe.

ProductLife Group (PLG), the specialized global provider of regulatory, scientific, vigilance and quality services for the life sciences industries, announces the acquisition of Intexo Società Benefit, an Italian consultancy specialized in regulatory and market access support. 

Founded in 1976, Intexo Società Benefit provides clients with an integrated market access and regulatory affairs offering covering access strategies, market and payer research, health economics evaluations, patient advocacy, negotiations and contracting, pricing and reimbursement as well as strategic regulatory. The group specializes in highly innovative products, including oncology, orphan drugs and advanced therapeutic medicinal products (ATMPs).
 

Mariangela Prada, CEO d'Intexo, said: 

“The merger with PLG creates the opportunity to provide a Europe-wide market access platform, while paving the way to developing a global market access community. The merger with PLG perfectly complements our service offerings by leveraging our strong local market expertise while providing our clients with broader reach. We are eager to see these opportunities unfold as they will bring vast benefits to our clients, team members and, in the end, to patients”.

Xavier Duburcq, CEO de PLG, stated : 

“The acquisition of Intexo fits with our objective to strengthen our health economics and market access expertise. As the pace of clinical development accelerates and the boundaries between medical, commercial, regulatory, access, and HEOR tend to merge, we see a huge opportunity to develop cutting-edge integrated service offerings for our clients.”

The RSM team

The RSM team involved was composed of 

• Financial due diligence : Eric Fougedoire, Luca D'Ambrosio, Francesco Greco.
• Tax and payroll due diligence : Kristian Bresciani, Alessandro Carturani.